ESC, ESH 2013

2013 ESH, ESC Guidelines:

( )

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

CV .

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

CV

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Clinical indications for out-of-office blood
pressure measurement for diagnostic purposes

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Secondary hypertension

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Physical examination for secondary
hypertension, organ damage and obesity

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

remodelling .

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

, ,
/
-

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Search for asymptomatic organ damage, cardiovascular disease,
and chronic kidney disease

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

/

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

. /
CVD

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Life-style

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

vs
.

G. Mancia et al EHJ June 2013

2013 ESH, ESC

Guidelines:
Major drug combinations
used in trials of
antihypertensive
treatment in a step-up
approach or as a
randomized
combination

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment strategies and choice of drugs

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment strategies in white-coat and masked
hypertension

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Antihypertensive treatment strategies in the elderly

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment strategies in hypertensive women

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment strategies in patients with diabetes

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment strategies in hypertensive patients with
metabolic syndrome

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Therapeutic strategies in hypertensive patients with
nephropathy

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Therapeutic strategies in hypertensive patients with
cerebrovascular disease

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Therapeutic strategies in
hypertensive patients with heart
disease

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Therapeutic strategies in hypertensive patients with
atherosclerosis, arteriosclerosis, and peripheral artery
disease

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Therapeutic strategies in patients with resistant
hypertension

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Treatment of risk factors associated with hypertension

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Sensitivity to detect treatment-induced changes, time
to change and prognostic value of change by
markers of asymptomatic OD.

G. Mancia et al EHJ June 2013

2013 ESH, ESC Guidelines:

Methodstoimprove adherence to physicians
recommendations

G. Mancia et al EHJ June 2013

Guidelines AACE 2013

Endocr Pract. 2013;19(2):327-336

Guidelines AACE 2013

Endocr Pract. 2013;19(2):327-336